Overview

Update
Most Recent Funding
$140M Debt Financing on June 29, 2016
Headquarters:
Philadelphia, Pennsylvania
Description:
Iroko Pharmaceuticals is a global specialty pharmaceutical company dedicated to advancing the science of analgesia.
Categories:
Pharmaceutical, Biotechnology, Life Science
Website:
http://iroko.com

Company Details

Update

In the short period since Iroko was founded in 2007, we have assembled a portfolio of proven pharmaceuticals, especially prescription pain medicines. Our goal has been to bring new life to these trusted products—new geographic markets, new indications, and new benefits through further development enabled by new technology.

We have already extended a distribution and sales network across more than 40 countries. And we have developed an industry-leading pipeline of nano-formulated lower-dose NSAIDs to address the need for new options in pain management.

Experience. Marketed products. A global presence. Innovation.

That’s Iroko. We’re an established company. And we’re hurrying to improve healthcare.

Funding Rounds (2) - $215M

Update
DateAmount / RoundValuationLead InvestorInvestors
Jun, 2016$140M / Debt Financing1
Nov, 2013$75M / Debt Financing1

Investors (2)

InvestorRound(s)Partner(s)
Debt Financing (Lead)-
Debt Financing (Lead)-

Current Team (3)

Update

Board Members and Advisors (2)

Update

Offices/Locations (1)

Update
  • Office

    One Kew Place

    150 Rouse Boulevard

    Philadelphia, Pennsylvania 19112

    United States

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos